Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Aug;30(8):1999–2005. doi: 10.1128/jcm.30.8.1999-2005.1992

Application of ubiquinone systems and electrophoretic comparison of enzymes to identification of clinical isolates of Aspergillus fumigatus and several other species of Aspergillus.

H Matsuda 1, S Kohno 1, S Maesaki 1, H Yamada 1, H Koga 1, M Tamura 1, H Kuraishi 1, J Sugiyama 1
PMCID: PMC265431  PMID: 1500506

Abstract

The ubiquinone systems and electrophoretic comparison of enzymes were used to determine the relatedness among 64 isolates of seven Aspergillus spp. These were 31 clinical and 3 nonclinical isolates of Aspergillus fumigatus Fres., 2 isolates of A. nidulellus Samson & W. Gams, 8 isolates of A. terreus Thom, 4 isolates of A. flavus Link, 1 isolate of A. oryzae (Ahlburg) Cohn, 14 isolates of A. niger van Tieghem, and 1 isolate of A. japonicus Saito. The enzymes glucose 6-phosphate dehydrogenase, lactate dehydrogenase, glutamate dehydrogenase, fumarase, and malate dehydrogenase were examined. The relative mobilities were analyzed numerically. The results were presented as a dendrogram. Isolates from clinical and nonclinical sources within the same species had identical ubiquinone systems and identical or very similar enzyme patterns. In the dendrogram, 64 of the tested isolates were separated into seven major clusters at a 60% similarity level. Each major cluster corresponds to a single species. On the dendrogram, A. fumigatus isolates showed homogeneity, whereas A. niger isolates showed relative heterogeneity; in particular, A. niger MF-24 and the other A. niger isolates were distantly linked to each other. All A. fumigatus isolates had the Q-10 ubiquinone system and formed a single major cluster at a similarity level of 73% or greater. Glucose 6-phosphate dehydrogenase and glutamate dehydrogenase were key enzymes for differentiating all clinical and nonclinical isolates of A. fumigatus from the other Aspergillus spp. Ubiquinone systems and enzyme patterns appear to be objective and useful indicators for use in the precise identification of clinical isolates of Aspergillus spp.

Full text

PDF
1999

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. doi: 10.1007/BF01964057. [DOI] [PubMed] [Google Scholar]
  2. Kurtzman C. P., Horn B. W., Hesseltine C. W. Aspergillus nomius, a new aflatoxin-producing species related to Aspergillus flavus and Aspergillus tamarii. Antonie Van Leeuwenhoek. 1987;53(3):147–158. doi: 10.1007/BF00393843. [DOI] [PubMed] [Google Scholar]
  3. Leslie C. E., Flannigan B., Milne L. J. Morphological studies on clinical isolates of Aspergillus fumigatus. J Med Vet Mycol. 1988;26(6):335–341. [PubMed] [Google Scholar]
  4. Moody S. F., Tyler B. M. Restriction enzyme analysis of mitochondrial DNA of the Aspergillus flavus group: A. flavus, A. parasiticus, and A. nomius. Appl Environ Microbiol. 1990 Aug;56(8):2441–2452. doi: 10.1128/aem.56.8.2441-2452.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Moody S. F., Tyler B. M. Use of nuclear DNA restriction fragment length polymorphisms to analyze the diversity of the Aspergillus flavus group: A. flavus, A. parasiticus, and A. nomius. Appl Environ Microbiol. 1990 Aug;56(8):2453–2461. doi: 10.1128/aem.56.8.2453-2461.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Nasuno S. Differentiation of Aspergillus sojae from Aspergillus oryzae by polyacrylamide gel disc electrophoresis. J Gen Microbiol. 1972 Jun;71(1):29–33. doi: 10.1099/00221287-71-1-29. [DOI] [PubMed] [Google Scholar]
  7. Schmitt H. J., Bernard E. M., Andrade J., Edwards F., Schmitt B., Armstrong D. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 1988 May;32(5):780–781. doi: 10.1128/aac.32.5.780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Van Cutsem J. The antifungal activity of ketoconazole. Am J Med. 1983 Jan 24;74(1B):9–15. doi: 10.1016/0002-9343(83)90508-9. [DOI] [PubMed] [Google Scholar]
  9. Van Cutsem J., Van Gerven F., Van de Ven M. A., Borgers M., Janssen P. A. Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother. 1984 Oct;26(4):527–534. doi: 10.1128/aac.26.4.527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Yamaguchi H., Hiratani T., Plempel M. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole. Arzneimittelforschung. 1983;33(4):546–551. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES